Biodegradable polymeric nanoparticles containing gold nanoparticles and paclitaxel for cancer imaging and drug delivery using photoacoustic methods

Biomedical Optics Express

Volumn 7, Issue 10, 2016, Pages 4125-4138

  Wang, Yanjie ^a,b,c   Strohm, Eric M ^a,b,c   Sun, Yang ^d   Wang, Zhaoxia ^d   Zheng, Yuanyi ^e   Wang, Zhigang ^d   Kolios, Michael C ^a,b,c  

^a RYERSON UNIVERSITY   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d CHONGQING MEDICAL UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Biomaterials; Fluorescence microscopy; Medical and biological imaging; Nanomaterials; Photoacoustic imaging

Indexed keywords

BIODEGRADABLE POLYMERS; BIOMATERIALS; CONTROLLED DRUG DELIVERY; DISEASES; FIBER OPTIC SENSORS; FLUORESCENCE MICROSCOPY; GOLD NANOPARTICLES; METAL NANOPARTICLES; NANOSTRUCTURED MATERIALS; ONCOLOGY; PHOTOACOUSTIC EFFECT; PHOTOACOUSTIC MICROSCOPY; TARGETED DRUG DELIVERY;

BIODEGRADABLE POLYMERIC NANOPARTICLES; CELL VIABILITY; CLINICAL TRANSLATION; DELIVERY CAPACITY; GOLD NANOPARTICLES (GNPS); MEDICAL AND BIOLOGICAL IMAGING; MULTIFUNCTIONAL THERANOSTIC AGENTS; PHOTO-ACOUSTIC IMAGING;

MEDICAL IMAGING;

GOLD NANOPARTICLE; PACLITAXEL; POLYGLACTIN;

ARTICLE; CANCER THERAPY; CELL VIABILITY; CONTROLLED STUDY; DRUG LOADING EFFICIENCY; DRUG RELEASE; FLUORESCENCE IMAGING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTERNALIZATION; MTT ASSAY; PARTICLE SIZE; PHOTOACOUSTICS; PHYSICAL PARAMETERS; SCANNING ELECTRON MICROSCOPY; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; VAPORIZATION;

EID: 84990060479     PISSN: None     EISSN: 21567085     Source Type: Journal    
DOI: 10.1364/BOE.7.004125     Document Type: Article

References (52)

1. X. Wang, Y. Wang, Z. G. Chen, and D. M. Shin, “Advances of Cancer Therapy by Nanotechnology,” Cancer Res. Treat. 41(1), 1–11 (2009).
2. R. Duncan, “Polymer conjugates as anticancer nanomedicines,” Nat. Rev. Cancer 6(9), 688–701 (2006).
3. I. Brigger, C. Dubernet, and P. Couvreur, “Nanoparticles in cancer therapy and diagnosis,” Adv. Drug Deliv. Rev. 54(5), 631–651 (2002).
4. J. Panyam and V. Labhasetwar, “Biodegradable nanoparticles for drug and gene delivery to cells and tissue,” Adv. Drug Deliv. Rev. 55(3), 329–347 (2003).
5. S. K. Sahoo and V. Labhasetwar, “Nanotech approaches to drug delivery and imaging,” Drug Discov. Today 8(24), 1112–1120 (2003).
6. A. Kumari, S. K. Yadav, and S. C. Yadav, “Biodegradable polymeric nanoparticles based drug delivery systems,” Colloids Surf. B Biointerfaces 75(1), 1–18 (2010).
7. J. Liu, J. Li, T. J. Rosol, X. Pan, and J. L. Voorhees, “Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro,” Phys. Med. Biol. 52(16), 4739–4747 (2007).
8. P. Kocbek, N. Obermajer, M. Cegnar, J. Kos, and J. Kristl, “Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody,” J. Control. Release 120(1-2), 18–26 (2007).
9. A. Lamprecht, N. Ubrich, H. Yamamoto, U. Schäfer, H. Takeuchi, P. Maincent, Y. Kawashima, and C.-M. Lehr, “Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease,” J. Pharmacol. Exp. Ther. 299(2), 775–781 (2001).
10. J. Panyam and V. Labhasetwar, “Sustained Cytoplasmic Delivery of Drugs with Intracellular Receptors Using Biodegradable Nanoparticles,” Mol. Pharm. 1(1), 77–84 (2004).
11. J. M. Koziara, T. R. Whisman, M. T. Tseng, and R. J. Mumper, “In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors,” J. Control. Release 112(3), 312–319 (2006).
12. A. A. Oraevsky, S. L. Jacques, and F. K. Tittel, “Determination of tissue optical properties by piezoelectric detection of laser-induced stress waves,” in Proceedings of Optics, Electro-Optics, & Laser Applications in Science& Engineering, (International Society for Optics and Photonics,1993), pp. 86–101.
13. E. Hysi, E. M. Strohm, and M. C. Kolios, “Probing Different Biological Length Scales Using Photoacoustics: From 1 To 1000 MHz,” in Handbook of Photonics for Biomedical Engineering, A. H.-P. Ho, D. Kim, and M. G. Somekh, Eds. (Springer, 2014).
14. M. Xu and L. V. Wang, “Photoacoustic imaging in biomedicine,” Rev. Sci. Instrum. 77(4), 041101 (2006).
15. P. Beard, “Biomedical photoacoustic imaging,” Interface Focus 1(4), 602–631 (2011).
16. P. Carmeliet and R. K. Jain, “Angiogenesis in cancer and other diseases,” Nature 407(6801), 249–257 (2000).
17. A. Roggan, M. Friebel, K. Do Rschel, A. Hahn, and G. Mu Ller, “Optical properties of circulating human blood in the wavelength range 400–2500 nm,” J. Biomed. Opt. 4(1), 36–46 (1999).
18. R. Weissleder, “A clearer vision for in vivo imaging,” Nat. Biotechnol. 19(4), 316–317 (2001).
19. A. A. Oraevsky, A. A. Karabutov, and E. V. Savateeva, “Enhancement of optoacoustic tissue contrast with absorbing nanoparticles,” in Proceedings of European Conference on Biomedical Optics, (International Society for Optics and Photonics, 2001), pp. 60–69.
20. C. Kim, E. C. Cho, J. Chen, K. H. Song, L. Au, C. Favazza, Q. Zhang, C. M. Cobley, F. Gao, Y. Xia, and L. V. Wang, “In Vivo Molecular Photoacoustic Tomography of Melanomas Targeted by Bioconjugated Gold Nanocages,” ACS Nano 4(8), 4559–4564 (2010).
21. J. A. Copland, M. Eghtedari, V. L. Popov, N. Kotov, N. Mamedova, M. Motamedi, and A. A. Oraevsky, “Bioconjugated gold nanoparticles as a molecular based contrast agent: implications for imaging of deep tumors using optoacoustic tomography,” Mol. Imaging Biol. 6(5), 341–349 (2004).
22. J. P. Culver, R. Choe, M. J. Holboke, L. Zubkov, T. Durduran, A. Slemp, V. Ntziachristos, B. Chance, and A. G. Yodh, “Three-dimensional diffuse optical tomography in the parallel plane transmission geometry: evaluation of a hybrid frequency domain/continuous wave clinical system for breast imaging,” Med. Phys. 30(2), 235–247 (2003).
23. Y. Sun, Y. Wang, C. Niu, E. M. Strohm, Y. Zheng, H. Ran, R. Huang, D. Zhou, Y. Gong, Z. Wang, D. Wang, and M. C. Kolios, “Laser-Activatible PLGA Microparticles for Image-Guided Cancer Therapy In Vivo,” Adv. Funct. Mater. 24(48), 7674–7680 (2014).
24. J. G. Riess, “Perfluorocarbon-based oxygen delivery,” Artif. Cells Blood Substit. Immobil. Biotechnol. 34(6), 567–580 (2006).
25. O. D. Kripfgans, J. B. Fowlkes, D. L. Miller, O. P. Eldevik, and P. L. Carson, “Acoustic droplet vaporization for therapeutic and diagnostic applications,” Ultrasound Med. Biol. 26(7), 1177–1189 (2000).
26. R. E. Apfel, “Activatable infusable dispersions containing drops of a superheated liquid for methods of therapy and diagnosis,” US5840276 A (1998).
27. P. S. Sheeran, S. Luois, P. A. Dayton, and T. O. Matsunaga, “Formulation and Acoustic Studies of a New Phase- Shift Agent for Diagnostic and Therapeutic Ultrasound,” Langmuir 27(17), 10412–10420 (2011).
28. E. Strohm, M. Rui, I. Gorelikov, N. Matsuura, and M. Kolios, “Vaporization of perfluorocarbon droplets using optical irradiation,” Biomed. Opt. Express 2(6), 1432–1442 (2011).
29. K. Wilson, K. Homan, and S. Emelianov, “Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging,” Nat. Commun. 3, 618 (2012).
30. W. Cui, J. Bei, S. Wang, G. Zhi, Y. Zhao, X. Zhou, H. Zhang, and Y. Xu, “Preparation and evaluation of poly(Llactide- co-glycolide) (PLGA) microbubbles as a contrast agent for myocardial contrast echocardiography,” J. Biomed. Mater. Res. B Appl. Biomater. 73B(1), 171–178 (2005).
31. E. Pisani, N. Tsapis, J. Paris, V. Nicolas, L. Cattel, and E. Fattal, “Polymeric Nano/Microcapsules of Liquid Perfluorocarbons for Ultrasonic Imaging: Physical Characterization,” Langmuir 22(9), 4397–4402 (2006).
32. K. E. Uhrich, S. M. Cannizzaro, R. S. Langer, and K. M. Shakesheff, “Polymeric systems for controlled drug release,” Chem. Rev. 99(11), 3181–3198 (1999).
33. M. L. Fabiilli, J. A. Lee, O. D. Kripfgans, P. L. Carson, and J. B. Fowlkes, “Delivery of Water-Soluble Drugs Using Acoustically Triggered Perfluorocarbon Double Emulsions,” Pharm. Res. 27(12), 2753–2765 (2010).
34. J. Spratlin and M. B. Sawyer, “Pharmacogenetics of paclitaxel metabolism,” Crit. Rev. Oncol. Hematol. 61(3), 222–229 (2007).
35. M. Ishitobi, E. Shin, and N. Kikkawa, “Metastatic breast cancer with resistance to both anthracycline and docetaxel successfully treated with weekly paclitaxel,” Int. J. Clin. Oncol. 6(1), 55–58 (2001).
36. M. Yokoyama, M. Miyauchi, N. Yamada, T. Okano, Y. Sakurai, K. Kataoka, and S. Inoue, “Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer,” Cancer Res. 50(6), 1693–1700 (1990).
37. M. Talelli, C. J. F. Rijcken, W. E. Hennink, and T. Lammers, “Polymeric micelles for cancer therapy: 3 C’s to enhance efficacy,” Curr. Opin. Solid State Mater. Sci. 16(6), 302–309 (2012).
38. J. Turkevich, P. C. Stevenson, and J. Hillier, “A study of the nucleation and growth processes in the synthesis of colloidal gold,” Discuss. Faraday Soc. 11(0), 55–75 (1951).
39. G. Frens, “Particle size and sol stability in metal colloids,” Kolloid-Z. Z. Für Polym. 250(7), 736–741 (1972).
40. N. G. Bastús, J. Comenge, and V. Puntes, “Kinetically Controlled Seeded Growth Synthesis of Citrate-Stabilized Gold Nanoparticles of up to 200 nm: Size Focusing Versus Ostwald Ripening,” Langmuir 27(17), 11098–11105 (2011).
41. S. H. Liu and M. Y. Han, “Synthesis, Functionalization, and Bioconjugation of Monodisperse, Silica-Coated Gold Nanoparticles: Robust Bioprobes,” Adv. Funct. Mater. 15(6), 961–967 (2005).
42. I. Gorelikov, A. L. Martin, M. Seo, and N. Matsuura, “Silica-coated quantum dots for optical evaluation of perfluorocarbon droplet interactions with cells,” Langmuir 27(24), 15024–15033 (2011).
43. Y. J. Wang, E. M. Strohm, Y. Sun, C. Niu, Y. Zheng, Z. Wang, and M. C. Kolios, “PLGA/PFC particles loaded with gold nanoparticles as dual contrast agents for photoacoustic and ultrasound imaging,” Proc. SPIE 8943, 89433M (2014).
44. S. L. Lombardi, ed., Nanoparticles: new research, (Nova Science Publishers, 2008).
45. Y.-S. Chen, W. Frey, S. Kim, P. Kruizinga, K. Homan, and S. Emelianov, “Silica-Coated Gold Nanorods as Photoacoustic Signal Nanoamplifiers,” Nano Lett. 11(2), 348–354 (2011).
46. Y. Matsumura and H. Maeda, “A New Concept for Macromolecular Therapeutics in Cancer Chemotherapy: Mechanism of Tumoritropic Accumulation of Proteins and the Antitumor Agent Smancs,” Cancer Res. 46(12 Pt 1), 6387–6392 (1986).
47. F. Yuan, M. Dellian, D. Fukumura, M. Leunig, D. A. Berk, V. P. Torchilin, and R. K. Jain, “Vascular Permeability in a Human Tumor Xenograft: Molecular Size Dependence and Cutoff Size,” Cancer Res. 55(17), 3752–3756 (1995).
48. C. L. Didychuk, P. Ephrat, A. Chamson-Reig, S. L. Jacques, and J. J. L. Carson, “Depth of photothermal conversion of gold nanorods embedded in a tissue-like phantom,” Nanotechnology 20(19), 195102 (2009).
49. C. W. Wei, M. Lombardo, K. Larson-Smith, I. Pelivanov, C. Perez, J. Xia, T. Matula, D. Pozzo, and M. O’Donnell, “Nonlinear contrast enhancement in photoacoustic molecular imaging with gold nanosphere encapsulated nanoemulsions,” Appl. Phys. Lett. 104(3), 033701 (2014).
50. A. J. Dixon, S. Hu, A. L. Klibanov, and J. A. Hossack, “Oscillatory Dynamics and In Vivo Photoacoustic Imaging Performance of Plasmonic Nanoparticle-Coated Microbubbles,” Small 11(25), 3066–3077 (2015).
51. J. L. Goldstein, R. G. W. Anderson, and M. S. Brown, “Coated pits, coated vesicles, and receptor-mediated endocytosis,” Nature 279(5715), 679–685 (1979).
52. D. B. Chithrani, “Intracellular uptake, transport, and processing of gold nanostructures,” Mol. Membr. Biol. 27(7), 299–311 (2010).